BetterLife Pharma Inc. (OTCMKTS:BETRF – Get Free Report) shot up 1.8% during mid-day trading on Monday . The stock traded as high as $0.2076 and last traded at $0.2070. 15,530 shares traded hands during trading, a decline of 91% from the average session volume of 174,831 shares. The stock had previously closed at $0.2033.
BetterLife Pharma Trading Up 1.8%
The business has a fifty day moving average price of $0.14 and a 200 day moving average price of $0.08.
About BetterLife Pharma
BetterLife Pharma Inc, a biotechnology company, engages in the development and commercialization of compounds for the treatment of mental disorders in Canada. It is also involved in refining and developing drug candidates from a set of complementary interferon-based technologies that have the potential to engage the immune system to fight virus infections. The company's products pipeline includes BETR-001 for the treatment of major depressive disorder, anxiety, and neuropathic pain and other neuro-psychiatric and neurological disorders; and BETR-002 to treat benzodiazepine dependency, anxiety, and neurodegenerative disorders.
Further Reading
- Five stocks we like better than BetterLife Pharma
- Commodities Are Booming, But These 3 ETFs Tell Different Stories
- 3 Active ETFs Making Big Moves in August
- This ETF Is Outperforming by Avoiding the S&P 500’s Biggest Problem
- Birkenstock Beats the Skeptics—But Not on EPS
Receive News & Ratings for BetterLife Pharma Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for BetterLife Pharma and related companies with MarketBeat.com's FREE daily email newsletter.
